Tyrphostin AG30
CAS: 122520-79-0
Ref. 3D-XEA52079
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen | ||
100mg | Ausgelaufen |
Produktinformation
- Tyrphostin AG 30
- (2E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enoic acid
Tyrphostin AG30 is a drug that has been shown to be effective in the treatment of autoimmune diseases and infectious diseases. It is a slow-release formulation, which means that it continues to release the active ingredient over time. The drug has been shown to bind to metal surfaces such as titanium and stainless steel, but not polyethylene terephthalate (PET) plastic. Tyrphostin AG30 interacts with messenger RNA (mRNA) and prevents the production of cytokines and angiogenic factors, which are involved in inflammatory processes. This drug also demonstrates minimal toxicity in an animal model and has been found to have no effect on the biological function of primary keratinocytes.